Results 151 to 160 of about 10,405 (214)

Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies. [PDF]

Curr Allergy Asthma Rep
Mendez P, Rosado A, Cardet JC.
europepmc   +1 more source

Blood Eosinophil Subtype-Specific Protein Gene Expression and Eosinophil-Derived Serum Mediators in Allergic Asthma Patients After Bronchial Challenge with <i>Dermatophagoides pteronyssinus</i>. [PDF]

Cells
Rimkunas A, Januskevicius A, Vasyle E, Palacionyte J, Miliauskas S, Malakauskas K.   +5 more
europepmc   +1 more source

Periostin and airway mucus plugs in nonasthmatic former smokers with and without COPD. [PDF]

ERJ Open Res
Tanabe N, Sato A, Matsumoto H, Ashino S, Sakamoto R, Sato S, Hirai T.   +6 more
europepmc   +1 more source

A Clinical Nomogram for Predicting Early Response to Biologics in Pediatric Allergic Asthma with Comorbid Allergic Rhinitis. [PDF]

J Asthma Allergy
Wang L, Kang Z, Ma J, Wang C, Jiang W, Huang J, Liu S.   +6 more
europepmc   +1 more source

Bridging the Knowledge Gap: Transforming COPD Management Through Lessons from Asthma. [PDF]

Pulm Ther
de Miguel-Díez J, Callejas-González FJ, Blanco-Aparicio M, Cosío BG, González-Villaescusa C, Santos S, Cabrera C.   +6 more
europepmc   +1 more source

Fractional Exhaled Nitric Oxide in Children with Non-Cystic Fibrosis Bronchiectasis: Associations with Etiology, Lung Function, and CT Extent. [PDF]

Pediatr Rep
Adiguzel T, Karadag B.
europepmc   +1 more source

Characteristics of severe asthma patients with biologic treatment in the Swedish National Airway Register. [PDF]

Eur Clin Respir J
Sundbom F, Palm A, Emilsson ÖI, Stridsman C.   +3 more
europepmc   +1 more source

Serum and Nasal Lavage Fluid Eosinophil-Derived Neurotoxin Levels in Clinically Defined Asthma Phenotypes. [PDF]

Clin Transl Allergy
Özuygur Ermis SS, Malmhäll C, Borres MP, Movérare R, Lisik D, Abohalaka R, Ercan S, Schmeisser S, Basna R, Mincheva R, Wennergren G, Lötvall J, Ekerljung L, Rådinger M, Kankaanranta H, Nwaru BI.   +15 more
europepmc   +1 more source

Development and Internal Evaluation of a Clinical-Physiological Model for Predicting Methacholine-Defined Airway Hyperresponsiveness in Children Aged 0-3 Years. [PDF]

J Asthma Allergy
Qin J, Liu S, Lin Y, Wang X, Zhao J, Liu F.   +5 more
europepmc   +1 more source

Biologic Therapies and Biomarkers in Severe Childhood Asthma: A Systematic Review of Omalizumab and Mepolizumab. [PDF]

Pediatr Pulmonol
Gusmão ABF, Marques BO, Gusmão ALF, de Lacerda RT, França APD, Silva EKD, Sousa GS, Pereira MN.   +7 more
europepmc   +1 more source